Evidence – Budesonide Is Safe, Effective Early and Late Treatment for COVID-19 – Promotion Statistics
This report provides an insightful analysis of the promotional outreach for the article titled “Evidence – Budesonide Is Safe, Effective Early and Late Treatment for COVID-19“. The data-driven charts included in this report illustrate the number of scholars contacted across various countries, as well as the engagement metrics—such as email openings, article link clicks, and responses received. By examining these key indicators, we aim to assess the article’s reach and impact within the global academic community.
Article Promotion & Performance Report
1. Total Recipients – 523390
2. Average Open Rate – 83.77%
3. Average Click Rate – 78.66%
4. Positive Responses – 76.85%
Key Engagement Metrics and statistical Charts
The article, title- Evidence – Budesonide Is Safe, Effective Early and Late Treatment for COVID-19 has been promoted across multiple countries, and the response has been outstanding. Here are some key highlights:
- High Engagement: The open rates and click-through rates have been exceptionally strong.
- Global Reach: Readers from different countries have shown great interest.
- Positive Feedback: The article has resonated well with audiences, receiving great responses.